ARCHIVES

DCT Advisers Ok Expansion of Phase 1, Phase 2 Testing

This article is from The Cancer Letter archive.

Vol. 18 No. 28 | July 10, 1992

Download PDF Visit The Full Archive

Related Articles

NCI Offers Fellowship Training In Epidemiology & Genetics.

February 18, 2000

ORI Says COMS Study Coordinator Committed Scientific Misconduct

April 12, 1996

In Brief: Brinkley Asks Subcommittee to Add $62.5 Million To NCI Budget for Unfunded Grants

May 11, 1979

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Study Finds Hormonal Therapy Reduces Risk Of Disease Progression In Prostate Cancer

July 27, 2001

Standard Surgical Protocol Improved Endometrial Staging

October 27, 2006